Search Results - Neal Shore

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Diagnosis and Management of Checkpoint Inhibitor Side Effects in Patients with Bladder Cancer: the Urologist’s Perspective by Neal Shore

    Published in Bladder Cancer (2020-12-01)
    Get full text
    Article


  2. 2

    Hormonal Intensification Should Start at the Low-risk Stage in Metastatic Prostate Cancer by Seyed Behzad Jazayeri, Lauren Folgosa Cooley, Abhishek Srivastava, Neal Shore

    Published in European Urology Open Science (2022-11-01)
    Get full text
    Article


  3. 3

    Treatment intensification with radium-223 plus enzalutamide in patients with metastatic castration-resistant prostate cancer by Neal Shore, Joan Carles, Ray McDermott, Neeraj Agarwal, Bertrand Tombal

    Published in Frontiers in Medicine (2024-10-01)
    Get full text
    Article


  4. 4

    Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer by Tomasz M. Beer, Neal Shore, Alicia Morgans, Kerri Winters‐Stone, Jeffrey S. Wefel, Daniel J. George

    Published in BJUI Compass (2022-11-01)
    Get full text
    Article


  5. 5

    Rethinking the Role of Saw Palmetto Extract for Men with Lower Urinary Tract Symptoms in North America by J. Curtis Nickel, Bilal Chughtai, Cosimo De Nunzio, Jamin Brahmbhatt, Neal Shore, Alexis E. Te, Bob Djavan

    Published in Uro (2022-06-01)
    Get full text
    Article


  6. 6

    426 A phase 3, single-arm study of CG0070 in subjects with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG) by Neal Shore, Ashish Kamat, Paul Anderson, James Burke, Donald Lamm, Ed Uchio, John McAdory, Paola Grandi, Tran Ben, Melody Keel

    Published in Journal for ImmunoTherapy of Cancer (2021-11-01)
    Article


  7. 7

    Prostate Cancer Detection by Novice Micro-Ultrasound Users Enrolled in a Training Program by Hannes Cash, Sebastian Hofbauer, Neal Shore, Christian P. Pavlovich, Stephan Bulang, Martin Schostak, Erik Planken, Joris J. Jaspars, Ferdinand Luger, Laurence Klotz, Georg Salomon

    Get full text
    Article


  8. 8

    Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer by Joe M. O’Sullivan, Rana R. McKay, Kambiz Rahbar, Karim Fizazi, Daniel J. George, Bertrand Tombal, Anja Schmall, Per Sandström, Frank Verholen, Neal Shore

    Published in Frontiers in Medicine (2022-12-01)
    Get full text
    Article


  9. 9

    Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-... by Gary R. Eldridge, Heidi Hughey, Lois Rosenberger, Steven M. Martin, Andrew Marc Shapiro, Elizabeth D’Antonio, Kent G. Krejci, Neal Shore, James Peterson, Andrea S. Lukes, Courtney M. Starks

    Published in Human Vaccines & Immunotherapeutics (2021-05-01)
    Get full text
    Article


  10. 10

    665 Immunotherapeutic trial in men with biochemical recurrence after definitive local therapy for prostate cancer: A clinical trial in progress by Neal Shore, Robert Dreicer, Matthew Zibelman, Mark N Stein, Ralph J Hauke, Russell Pachynski, Bethan Jones, Jessica Hawley, Charlotte Davis, Katie Anderson, Antonella Vardeu, Margaret A Marshall, Vicky Wheeler, Sarah Sebastian, Kevin Kayvan Zarrabi, Brian Miles, Jennifer Bendall

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  11. 11

    Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer by Gary D Steinberg, Neal Shore, Petros Grivas, Matthew D Galsky, Elizabeth R Plimack, Shilpa Gupta, Arjun V Balar, Peter C Black, Matthew T Campbell, Gail S Dykstra, Christoper J Hoimes, Lidia P Lopez, Joshua J Meeks, Jonathan E Rosenberg, Ashish M Kamat

    Published in Journal for ImmunoTherapy of Cancer (2021-07-01)
    Get full text
    Article


  12. 12

    O12: Real world impact of germline genetic testing on clinical decision making for prostate cancer patients* by Neal Shore, Christopher Pieczonka, Mukaram Gazi, Sean Heron, David Cahn, Laurence Belkoff, Aaron Berger, Brian Mazzarella, Joseph Veys, David Morris, Alexander Engelman, Paul Dato, Richard Bevan-Thomas, Kathryn Hatchell, Robert Cornell, David R. Wise, Brandie Heald, Sarah Nielsen (Young), Robert Nussbaum, Edward Esplin

    Published in Genetics in Medicine Open (2023-01-01)
    Get full text
    Article


  13. 13

    B2B: Prostate Cancer Summary by Stacy Loeb, Peter C. Black, Alexander W. Wyatt, Yaw A. Nyame, Neal Shore, Derya Tilki, Elena Castro, Matthew Cooperberg, Veda Giri, Maria J. Ribal, Giovanni Lughezzani, Rafael Sánchez-Salas, Caroline M. Moore, Art Rastinehad, Linda Kerkmeijer, Hashim U. Ahmed, Shusuke Akamatsu, Alexandre de la Taille, Martin Gleave, Simon Tanguay

    Get full text
    Article


  14. 14

    Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer by Elaine Chang, Noah M. Hahn, Seth P. Lerner, Jaleh Fallah, Sundeep Agrawal, Ashish M. Kamat, Vishal Bhatnagar, Robert S. Svatek, Adnan A. Jaigirdar, Peter Bross, Neal Shore, Max Kates, Karen Sachse, Jamie R. Brewer, Michael A. O’Donnell, Gary D. Steinberg, Charles J. Viviano, Erik Bloomquist, Maria J. Ribal, Matthew D. Galsky, Richard Oliver, Peter C. Black, Hikmat Al-Ahmadie, Kenneth Brothers, Kamal Pohar, Colin P. Dinney, Zhou Feng, Tracy M. Downs, Sima P. Porten, Angela B. Smith, Rick Bangs, Sarah P. Psutka, Neeraj Agarwal, Laleh Amiri-Kordestani, Daniel L. Suzman, Richard Pazdur, Paul G. Kluetz, Chana Weinstock

    Published in Bladder Cancer (2023-09-01)
    Get full text
    Article


Search Tools: